Navigation Links
PNH in Medical News

Researchers to Present Additional Data on Soliris(R) (eculizumab) for the Treatment of PNH at the ASH Annual Meeting

Initial Physician Experience with Eculizumab in Patients with Other Rare Complement-Mediated Diseases also to be Presented CHESHIRE, Conn., Nov. 10 /PRNewswire-FirstCall/ -- Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN ) today announced that the American Society of Hematology (ASH) has publi...

Alexion Pharmaceuticals to Present Data on Soliris(R) (Eculizumab) and PNH at the 2007 American Society of Hematology (ASH) Annual Meeting

CHESHIRE, Conn., Dec. 7 /PRNewswire-FirstCall/ -- Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN ) today announced that data relating to paroxysmal nocturnal hemoglobinuria (PNH), as well as to Soliris(R) (eculizumab), a treatment for patients with PNH, will be presented at the 2007 American Soc...

Alexion Pharmaceuticals and PDL BioPharma Resolve Patent Dispute

... About Soliris Soliris is the first product approved for the treatment of paroxysmal nocturnal hemoglobinuria (PNH) in the U.S. and Europe. pnh is a rare, debilitating, and life-threatening blood disorder defined by the destruction of red blood cells, or hemolysis. In patients with PNH, hemoly...

Connecticut Bioscience Achievement Awards Presented at CURE Annual Meeting

...t biotechnology company to have a product approved for marketing. Earlier this year Alexion launched Soliris(R), a pharmaceutical for the treatment of pnh (paroxysmal nocturnal hemoglobinuria), a rare blood disorder. Dr. Leonard Bell is CEO and David Keiser is president and COO of Alexion. The Atlas Aw...

Nerve Disorganization May Spur Form of Dyslexia

...(PNH), which disrupts brain structure. People with pnh have normal intelligence but have trouble reading ...d for this aspect of reading. They compared the pnh patients to 10 people with dyslexia without neurol...atter nerve fiber connections in the brains of the pnh patients. The more disordered a patient's white ma...

FDA Approves First-of-its-Kind Drug to Treat Rare Blood Disorder

...g upon the severity of the disorder, patients with pnh may have pain, fatigue and debilitating weakness, ...ment system activity, including the destruction of pnh red blood cells. FDA based its approval on ...cebo-controlled clinical study of 87 patients with pnh and a series of other clinical studies. The contro...
PNH in Medical Technology

Soliris(R) Improved Fatigue Independent of Changes in Anemia in Patients with PNH by Controlling Hemolysis

Data Suggest Role of Hemolysis in PNH-Related Fatigue Presentation at the European Hematology Association 13th Congress CHESHIRE, Conn., June 15 /PRNewswire-FirstCall/ -- Soliris(R) (eculizumab) therapy improved the often disabling fatigue experienced by patients with the rare blood...

Alexion Completes Enrollment in AEGIS Registration Study of Soliris(R) (eculizumab) in Patients with PNH in Japan

CHESHIRE, Conn., March 20 /PRNewswire-FirstCall/ -- Alexion Pharmaceuticals, Inc. (the "Company") (Nasdaq: ALXN ) today announced that it has completed enrolling patients in its previously announced AEGIS study, a single registration study to evaluate the safety, efficacy, and pharmacology of...

Alexion Commences Dosing in AEGIS Registration Study of Soliris(R) (eculizumab) in Patients with PNH in Japan

CHESHIRE, Conn., Jan. 7 /PRNewswire-FirstCall/ -- Alexion Pharmaceuticals, Inc. (the "Company," Nasdaq: ALXN) today announced that it has commenced dosing in the AEGIS study, a single registration study to evaluate the safety, efficacy, and pharmacology of Soliris(R) (eculizumab) as a treatmen...

PNH Patients With Lower Levels of Hemolysis, Mild Anemia and Minimal Transfusion Support Have Significant Disease Burden; Soliris(R) Therapy Provided Clinical Improvements in PNH Patients Regardless of Disease Severity

Data Presented at the American Society of Hematology (ASH) Annual Meeting Publication Number: 840 CHESHIRE, Conn., Dec. 11 /PRNewswire-FirstCall/ -- Soliris(R) (eculizumab) therapy reduced hemolysis, fatigue, thromboses (blood clots) and transfusion requirements in patien...

Soliris(R) Demonstrates Reductions in Hemolysis and Improvements in Fatigue, Overall Quality of Life and Anemia in a Broad Population of PNH Patients

Results of SHEPHERD Phase III Open Label Trial Published in Online Edition of the Journal Blood CHESHIRE, Conn., Dec. 4 /PRNewswire-FirstCall/ -- Soliris(R) (eculizumab) therapy reduced hemolysis and improved fatigue, overall quality of life and anemia in a diverse popu...

Alexion Reports Positive Results from AEGIS Registration Study of Soliris in Japanese Patients With PNH

CHESHIRE, Conn., Dec. 8 /PRNewswire-FirstCall/ -- Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN ) today reported positive results from AEGIS, an open-label registration study examining Soliris(R) (eculizumab) treatment of Japanese patients with paroxysmal nocturnal hemoglobinuria (PNH). The pre-sp...

Long-Term Soliris(R) Therapy Improved or Stabilized Kidney Function in Patients With PNH

Study Shows that Long-Term Soliris Therapy Continued to Be Associated with Reductions in Thrombosis and Improvements in Fatigue, Quality of Life, and Anemia in PNH Patients Data Presented at the American Society of Hematology (ASH) Annual Meeting Po...

Soliris Effective in PNH Patients With History of Aplastic Anemia and Myelodysplastic Syndromes

- Analysis of Phase III Data Presented at ASCO - CHICAGO, June 04, 2007 /PRNewswire-FirstCall/ -- Investigators reported today that Soliris(TM) (eculizumab), a new treatment for paroxysmal nocturnal hemoglobinuria (PNH) developed by Alexion Pharmaceuticals, Inc. , is effective in patients diagnose...

Studies Show Efficacy and Safety of Alexion's Soliris in Broad Population of PNH Patients

- Data presented at 12th Congress of European Hematology - CHESHIRE, Conn., June 11, 2007 /PRNewswire-FirstCall/ -- Alexion Pharmaceuticals, Inc. today announced results from three analyses of Phase III studies examining Soliris(TM) (eculizumab) for the treatment of paroxysmal nocturnal hemoglobin...

First Clinical Experience With Soliris(R) in Treating Patients With Two Rare Complement-Mediated Diseases Presented at ASH Annual Meeting

...h PNH. Soliris is the first therapy approved in Europe for the treatment of pnh and was the first medicinal product to receive EC approval under the EMEA A...tibiotics if necessary." During clinical studies, two out of 196 vaccinated pnh patients treated with Soliris experienced a serious meningococcal infection...
PNH in Biological Technology

Soliris(R) Reduced Measures of Thrombosis and Inflammation, and Decreased Indicators of Pulmonary Hypertension, in Studies of Patients with PNH

CHESHIRE, Conn., Dec. 9 /PRNewswire-FirstCall/ -- Soliris(R) (eculizumab), a terminal complement inhibitor developed by Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN ), was observed by investigators to reduce blood measures associated with undiagnosed blood clots and inflammation in patients with ...

Alexion Reports Third Quarter 2008 Results

... "The Award reflects our ongoing commitment to the pnh community, and also points to the potential of our...ith the FDA approval of Soliris as a treatment for pnh in 2007, Alexion became the first company to disco...PNH, resulting in more effective identification of pnh patients. In Europe, more patients in more countri...

Alexion's Soliris(R) Receives 2008 Prix Galien USA Award for Best Biotechnology Product

...mponent of the normal immune system. Patients with pnh lack naturally occurring proteins that ordinarily ...e committed to making sure that every patient with pnh who can benefit from Soliris will have access to S...cess of Soliris by increasing our understanding of pnh and by evaluating the promise of complement inhibi...

Alexion Reports First Quarter 2008 Results

... Growing Awareness of pnh Drives Strong Demand for Soliris(R) in U.S. and ...akes it possible for us to help more patients with pnh and research promising therapies for other serious...opment: Soliris as a Treatment for Patients with pnh -------------------------------------------- A...

Alexion Reports Fourth Quarter and Full Year 2007 Results

...of urgency in detecting and treating patients with pnh as early as possible," said Leonard Bell, M.D., Ch...ontinue to execute our launch plan by facilitating pnh patient access to Soliris, while also assisting ph...ysicians, through education, to diagnose and treat pnh with greater effectiveness," said David Keiser, Pr...

PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials

...all/ -- Patients with a rare blood disorder called pnh experienced a 92 percent reduction in the incidenc...ombosis is the leading cause of premature death in pnh patients and the most feared complication of PNH,"... clinical trials, Soliris reduced hemolysis in all pnh patients and significantly improved anemia, fatigu...
Other Tags
(Date:9/18/2014)... Schaumburg, IL (PRWEB) September 18, 2014 ... proving itself a boon to contractors and homeowners ... construction dust that overtakes the home, causes potential ... project. Now available nationwide, the BuildClean system allows ... from demolition, sanding and other standard remodeling tasks. ...
(Date:9/18/2014)... VA (PRWEB) September 18, 2014 Results ... just been released and it reveals that pornography is ... and also harms marriages. The findings are based upon ... ) and conducted by Barna Group among a nationally ... survey included numerous questions focusing upon the frequency of ...
(Date:9/18/2014)... Randy Dotinga HealthDay Reporter ... who have the largest number of post-traumatic stress disorder symptoms ... to food, a new study suggests. The findings ... or becoming addicted to food. And it,s also possible that ... PTSD, or both. Still, the research seems to ...
(Date:9/18/2014)... Recently, WowBobble.com, the popular online supplier of funny ... to its product line. Moreover, all the company’s products ... customers can enjoy the special offer before September 29, 2014. ... prices ($12.5 for each bobblehead doll ). , ... bobbleheads. We want to make our interesting items available to ...
(Date:9/18/2014)... September 18, 2014 A positive outlook on ... improve your health. This year, at the Weekend for Women ... that adored LA radio talk show host Mother Love will ... with diabetes. , The always-funny Jo Anne Hart, aka ... best known for her widely acclaimed talk show on LATalkRadio.com, ...
Breaking Medicine News(10 mins):Health News:New BuildClean™ System Brings Livability Back to Home Remodeling 2Health News:New BuildClean™ System Brings Livability Back to Home Remodeling 3Health News:New BuildClean™ System Brings Livability Back to Home Remodeling 4Health News:2014 Study shows that pornography is an addiction that risks employment and harms marriages 2Health News:2014 Study shows that pornography is an addiction that risks employment and harms marriages 3Health News:2014 Study shows that pornography is an addiction that risks employment and harms marriages 4Health News:2014 Study shows that pornography is an addiction that risks employment and harms marriages 5Health News:PTSD Link to Food Addiction Seen in Report 2Health News:PTSD Link to Food Addiction Seen in Report 3Health News:Discounted Custom Bobbleheads Online For Sale At WowBobble.com 2Health News:DiabetesSisters Showcases Radio Talk Show Host Mother Love at Weekend for Women Conference in Los Angeles 2
(Date:9/18/2014)... probably the ultimate form of camouflage: you don,t just ... strategy is not as uncommon as you might think. ... USA, explains that the larval life stages of many ... of the anatomy that most creatures cannot make transparent. ... to shield each individual eye unit with an opaque ...
(Date:9/17/2014)... From accessible and affordable health care to reproductive ... depend on the ability of people to identify ... openly and respectfully, and find the most defensible ... practices to support these societal conversations?, The Hastings ... of Bioethical Issues have teamed up to publish ...
(Date:9/17/2014)... student have designed a device based on a shorebird,s ... dew., The device could provide water in drought-stricken areas ... Luo, professor in the Mechanical & Aerospace Engineering Department, ... of Engineering department, published "Bioinspired Plate-Based Fog Collectors" in ... Applied Materials & Interfaces journal. ...
Breaking Biology News(10 mins):Transparent larvae hide opaque eyes behind reflections 2Why bioethics literacy matters 2Why bioethics literacy matters 3Shorebird's beak inspires UT Arlington research on water collection 2
Other Contents